ONEOK (NYSE:OKE) reported quarterly earnings of $0.92 per share which beat the analyst consensus estimate of $0.90 by 2.22 percent. This is a 19.48 percent increase over earnings of $0.77 per share from the same period last year.
FDA Withdraws Lone Premature Birth Drug Makena Over Lack of Proven Benefits
Today, the FDA announced the final decision to withdraw approval of Privately held-Covis Pharma’s Makena (hydroxyprogesterone caproate injection), a drug approved…